New
VRF is proud to highlight a new patient support initiative launched by Incyte, named Opzelura On Trac. This program is designed for U.S. patients diagnosed with vitiligo who are prescribed Opzelura, providing essential support for those navigating the complexities of insurance coverage for their treatment.
Opzelura On Trac is distinguished by its financial assistance component, allowing qualified patients to significantly lessen their personal cost. Through a copay savings scheme, eligible participants may reduce their expenses to potentially $0 for each tube of Opzelura, which normally costs upwards of $2,000 for a 60-g tube. Additionally, IncyteCARES Patient Assistance Program exists to provide further financial aid to those in need.
Beyond financial support, the initiative equips patients with a comprehensive set of resources aimed at improving their understanding and management of vitiligo. This includes a dedicated application to assist patients through their treatment journey and an extensive FAQ section addressing common queries and concerns regarding JAK inhibitor treatments. For more information, visit OpzeluraOnTrac.com.
The VR Foundation continues its commitment to spotlighting innovative solutions and support mechanisms that contribute to vitiligo research, treatment, and comprehension. We encourage you to explore such resources as part of your holistic vitiligo management strategy.
FAQOther Questions
- Is there a link between vitiligo and depression?
Yes, depression and anxiety often occur alongside vitiligo and can greatly affect a person's quality of life. The connection comes from the fact that both the skin and brain dev...
- Vitiligo and hearing loss: any connection?
Vitiligo, primarily known for skin discoloration, can also affect melanocytes in the inner ear, potentially influencing hearing. Hearing loss isn't unique to vitiligo patients a...
- Polypodium leucotomos as an adjunct treatment for vitiligo?
Extracts of the tropical fern Polypodium leucotomos appear to have beneficial properties for the vitiligious skin. Polypodium leucotomos (also classified as Polypodium aureum) a...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.